120 STAT. 3690
PUBLIC LAW 109–482—JAN. 15, 2007 ‘‘(B) In the case of clinical research, the catalog shall, as appropriate, identify study populations by demographic variables and other variables that contribute to research on minority health and health disparities. ‘‘(C) Research activities listed in the catalog shall include, where applicable, the following: ‘‘(i) Epidemiological studies and longitudinal studies. ‘‘(ii) Disease registries, information clearinghouses, and other data systems. ‘‘(iii) Public education and information campaigns. ‘‘(iv) Training activities, including— ‘‘(I) National Research Service Awards and Clinical Transformation Science Awards; ‘‘(II) graduate medical education programs, including information on the number and type of graduate degrees awarded during the period in which the programs received funding under this title; ‘‘(III) investigator-initiated awards for postdoctoral training; ‘‘(IV) a breakdown by demographic variables and other appropriate categories; and ‘‘(V) an evaluation and comparison of outcomes and effectiveness of various training programs. ‘‘(v) Clinical trials, including a breakdown of participation by study populations and demographic variables and such other information as may be necessary to demonstrate compliance with section 492B (regarding inclusion of women and minorities in clinical research). ‘‘(vi) Translational research activities with other agencies of the Public Health Service. ‘‘(5) A summary of the research activities throughout the agencies, which summary shall be organized by the following categories, where applicable: ‘‘(A) Cancer. ‘‘(B) Neurosciences. ‘‘(C) Life stages, human development, and rehabilitation. ‘‘(D) Organ systems. ‘‘(E) Autoimmune diseases. ‘‘(F) Genomics. ‘‘(G) Molecular biology and basic science. ‘‘(H) Technology development. ‘‘(I) Chronic diseases, including pain and palliative care. ‘‘(J) Infectious diseases and bioterrorism. ‘‘(K) Minority health and health disparities. ‘‘(L) Such additional categories as the Director determines to be appropriate. ‘‘(6) A review of each entity receiving funding under this title in its capacity as a center of excellence (in this paragraph referred to as a ‘center of excellence’), including the following: ‘‘(A) An evaluation of the performance and research outcomes of each center of excellence.
VerDate 14-DEC-2004
12:05 Jul 13, 2007
Jkt 059194
PO 00003
Frm 00493
Fmt 6580
Sfmt 6581
E:\PUBLAW\PUBL003.109
APPS06
PsN: PUBL003
�
